Intellia Therapeutics (NTLA): ARK Investment Management reduced its stake -950K shares

15.9M

Shares reported · -950K vs prior quarter

1.1%

Disclosed portfolio weight

$192M

Reported value

Holdings as of

Sep 30, 2026

Filed

Nov 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 2, 2026InsiderOfficer sold ~$23K of NTLA shares in the open market
2. Nov 2, 2026InsiderCEO sold ~$108K of NTLA shares in the open market
3. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
4. Nov 10, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.6%
5. Nov 12, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Intellia Therapeutics

For Intellia Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NTLA page.

How this filing works

• SEC Form 13F

Other disclosures at Intellia Therapeutics

• SEC Form 4Nov 3, 2026
• SEC Form 144Nov 2, 2026
• SEC Form 4Oct 7, 2026
• SEC Form 144Oct 5, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its NTLA page.